ArticleScientific data2026
A Multiple Sclerosis MRI Dataset with Tri-Mask Annotations for Lesion Segmentation.
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A Robust Dual-Stage Learning-Based Pipeline for Multiclass Segmentation of Multiple Sclerosis Lesions in MRI.Diagnostics (Basel, Switzerland) · 2026Article
- Deep learning-based neuroanatomical profiling reveals population-specific brain changes in multiple sclerosis: a large-scale Middle Eastern study.BMC medical imaging · 2026Observational
- A Multiple Sclerosis MRI Dataset with Tri-Mask Annotations for Lesion Segmentation.Scientific data · 2026Article
- Multi-scale Gaussian product-of-experts for missing sequence multiple sclerosis lesion segmentation.Frontiers in radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis (MS) lesion segmentation from MRI is essential for diagnosis, monitoring, and treatment evaluation, yet existing datasets exhibit limited geographic diversity, scanner vendor bias, and inability to distinguish normal from pathological white matter hyperintensities. We present MS3SEG, a publicly available dataset comprising 100 MS patients from an Iranian cohort acquired on a 1.5 T Toshiba scanner, featuring multi-sequence MRI (T1-weighted, T2-weighted, T2-FLAIR in axial and sagittal planes) with novel tri-mask annotations. Expert annotators systematically delineated three classes on axial T2-FLAIR images: ventricles, normal white matter hyperintensities (age-related or CSF-contaminated regions), and abnormal white matter hyperintensities (MS lesions), incorporating automated quality control to minimize annotation errors. This tri-mask framework addresses a critical clinical challenge where benign periventricular hyperintensities are frequently misclassified as pathological lesions. Data are provided in multiple formats: raw DICOM, preprocessed NIfTI with co-registration and brain extraction, ground-truth masks, and visualization overlays. Baseline validation using U-Net, U-Net++, UNETR, and Swin UNETR across 5-fold cross-validation demonstrated dataset quality, with U-Net achieving Dice coefficients of 0.7469 for binary lesion segmentation and 0.6686 for multi-class abnormal hyperintensity segmentation. MS3SEG enables research on anatomically-aware segmentation, algorithm robustness to real-world clinical acquisition variations, and clinically relevant normal-versus-abnormal hyperintensity distinction, complementing existing 3D volumetric MS datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.